News + Filings Transactions
|
Young Jonathan
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 490 | $21.10 | $10.3k | | 10/02/2023 |
10/02/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 490 | $51.10 | $25k | | 10/02/2023 |
06/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 538 | $55.16 | $29.7k | | 06/13/2023 |
03/10/2023 | Akero Therapeutics, Inc. | AKRO | Payment of Exercise | Common Stock | 634 | $43.47 | $27.6k | | 03/10/2023 |
01/03/2023 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 8.8k | $0.62 | $5.4k | | 01/03/2023 |
01/03/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 8.8k | $54.64 | $479.6k | | 01/03/2023 |
12/27/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 722 | $0.62 | $444 | | 12/27/2022 |
12/27/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 11.8k | $6.36 | $74.9k | | 12/27/2022 |
12/27/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 12.5k | $49.57 | $619.6k | | 12/27/2022 |
12/16/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.4k | | 12/16/2022 |
12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 19.2k | $0.00 | $0 | | 12/09/2022 |
12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 86.4k | $42.95 | $3.7M | | 12/09/2022 |
09/13/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
09/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
01/07/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 1.4k | $0.62 | $890.5 | | 01/07/2022 |
01/07/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 26.3k | $0.62 | $16.2k | | 01/07/2022 |
12/08/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 87.2k | $21.10 | $1.8M | | 12/08/2021 |
11/04/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 6.2k | $24.33 | $151.3k | | 11/03/2021 |
11/03/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 18.8k | $24.27 | $455.8k | | 11/03/2021 |
09/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 12.5k | $24.04 | $300.5k | | 09/01/2021 |
07/15/2021 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 9k | $0.62 | $5.5k | | 07/15/2021 |
06/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.1k | $26.24 | $80.2k | | 06/01/2021 |
05/03/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.1k | $30.56 | $93.4k | | 05/03/2021 |
04/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.1k | $28.75 | $87.8k | | 04/01/2021 |
03/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 2.9k | $30.43 | $86.9k | | 03/01/2021 |
03/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 200 | $31.17 | $6.2k | | 03/01/2021 |
02/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 2.9k | $29.19 | $83.3k | | 02/01/2021 |
02/01/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 200 | $29.92 | $6k | | 02/01/2021 |
01/08/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 10k | $28.12 | $281.2k | | 01/07/2021 |
01/07/2021 | Akero Therapeutics, Inc. | AKRO | Exercise | Employee Stock Option (Right to Buy) | 7.5k | $0.62 | $4.6k | | 01/07/2021 |
01/04/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3k | $25.27 | $74.8k | | 01/04/2021 |
01/04/2021 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 100 | $26.00 | $2.6k | | 01/04/2021 |
12/08/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 77.6k | $28.35 | $2.2M | | 12/08/2020 |
06/30/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $17.07 | $21.2k | | 12/08/2020 |
03/13/2020 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 6.1k | $0.62 | $3.7k | | 03/13/2020 |
|
|